Malat1 expression is substantially higher in CRPC than in primary prostate cancer, and knocking it down resulted in decreased cell proliferation, invasion and migration, as well as in an increase in apoptosis (Ren et al., 2013). This evidence concerns the gene MALAT1 and prostate carcinoma.